Why Teladoc Health, Inc.’s (TDOC) Stock Is Up 30.45%
As of Thursday, October 29, Teladoc Health, Inc.’s TDOC share price has surged by 30.45%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Technology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Rosalio Madrigal
Michael Rose
Michael Rose
Tudor Pop
| Share Statistics | TDOC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,768.2 | $197.6 | 53% |
|
| Shares Out (Mil) | 181.9 | 45.1 | 74% |
|
| Institutional Ownership | 99.2% | 77.8% | 85% |
|
| Float (Mil) | 181.0 | 40.0 | 72% |
|
| Beta | 2.14 | 1.12 | 93% |
|
| Avg Daily Volume (000s) | 6,905 | 239 | 94% |
|
| Price Change (52-week) |
19.2% | 51.2% | 66% |
|
| Growth | TDOC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 18.3% | 13.5% | 79% |
|
| Net Income (5yr) | 16.2% | 5.4% | 66% |
|
| EPS (5yr) | 26.7% | 15.5% | 78 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (26.3%) | (15.5%) | 24% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 4 | 5 | |
| Current EPS | ($0.130) | ($0.680) | ($0.630) | |
| Month Ago EPS | ($0.115) | ($0.783) | ($0.785) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.115) | ($0.783) | ($0.785) | |
| Year/Year Chg | (12.2%) | (40.2%) | (30.3%) | |
| Financials | TDOC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,468 | $192 | 63% |
|
| Net Income (TTM) (Mil) | ($155) | ($9) | 8% |
|
| EPS (TTM) | ($0.860) | ($0.900) | 23% |
|
| Operating Cash Flow (TTM) (Mil) | $268 | ($1) | 63% |
|
| Net Cash Flow (TTM) (Mil) | $124 | $2 | 79% |
|
| Long-Term Debt (Q1) (Mil) | $28 | $16 | 35% |
|
| Enterprise Value (Q1) (Mil) | $1,737 | $180 | 47% |
|
| Valuation | TDOC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.37 | 1.41 | 38% |
|
| P/E | na | 44.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.8 | na |
|
| Ratios | TDOC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 68.6% | 61.1% | 80% |
|
| Net Margin | (6.3%) | (24.1%) | 24% |
|
| ROA | (5.5%) | (20.0%) | 29% |
|
| ROE | (11.5%) | (6.7%) | 27% |
|
| Liabilities to Assets | 53.3% | 32.5% | 46% |
|
| F-Score | 5 | 4 | 50% |
|
Teladoc Health, Inc. did not pass any screens on 11/4/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors